The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 2,712 | 2,608,117 | SH | SOLE | 2,608,117 | 0 | 0 | ||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | 3,354 | 232,571 | SH | SOLE | 232,571 | 0 | 0 | ||
| Akero Therapeutics, Inc. | COM | 00973Y108 | 1,060 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| Allakos Inc | COM | 01671P100 | 12,055 | 270,965 | SH | SOLE | 270,965 | 0 | 0 | ||
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | 781 | 195,195 | SH | SOLE | 195,195 | 0 | 0 | ||
| Aravive Inc | COM | 03890D108 | 3,318 | 576,066 | SH | SOLE | 576,066 | 0 | 0 | ||
| Atreca Inc | COM | 04965G109 | 9,878 | 596,838 | SH | SOLE | 596,838 | 0 | 0 | ||
| Bellus Health Inc | COM | 07987C204 | 3,917 | 394,431 | SH | SOLE | 394,431 | 0 | 0 | ||
| Bluebird Bio Inc | COM | 09609G100 | 1,139 | 24,790 | SH | SOLE | 24,790 | 0 | 0 | ||
| Catabasis Pharmaceuticals Inc | COM | 14875P206 | 1,245 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Hookipa Pharma Inc | COM | 43906K100 | 4,375 | 530,245 | SH | SOLE | 530,245 | 0 | 0 | ||
| Intercept Pharmaceuticals Inc | COM | 45845P108 | 25,416 | 403,688 | SH | SOLE | 403,688 | 0 | 0 | ||
| Iveric Bio, Inc. | COM | 46583P102 | 2,967 | 862,552 | SH | SOLE | 862,552 | 0 | 0 | ||
| Kala Pharmaceuticals Inc | COM | 483119103 | 563 | 64,102 | SH | SOLE | 64,102 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc | COM | 483497103 | 1,287 | 168,174 | SH | SOLE | 168,174 | 0 | 0 | ||
| Liquidia Technologies Inc | COM | 53635D202 | 4,775 | 1,013,773 | SH | SOLE | 1,013,773 | 0 | 0 | ||
| Millendo Therapeutics Inc | COM | 60040X103 | 3,967 | 751,301 | SH | SOLE | 751,301 | 0 | 0 | ||
| Odonate Therapeutics Inc | COM | 676079106 | 14,430 | 522,637 | SH | SOLE | 522,637 | 0 | 0 | ||
| Pieris Pharmaceuticals Inc | COM | 720795103 | 3,694 | 1,620,249 | SH | SOLE | 1,620,249 | 0 | 0 | ||
| Portola Pharmaceuticals Inc | COM | 737010108 | 1,139 | 159,772 | SH | SOLE | 159,772 | 0 | 0 | ||
| Principia Biopharma Inc | COM | 74257L108 | 23,814 | 401,046 | SH | SOLE | 401,046 | 0 | 0 | ||
| Rhythm Pharmaceuticals Inc | COM | 76243J105 | 4,205 | 276,289 | SH | SOLE | 276,289 | 0 | 0 | ||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 1,788 | 128,197 | SH | SOLE | 128,197 | 0 | 0 | ||
| Springworks Therapeutics Inc | COM | 85205L107 | 16,883 | 625,281 | SH | SOLE | 625,281 | 0 | 0 | ||
| Sunesis Pharmaceuticals Inc | COM | 867328700 | 2,464 | 5,938,215 | SH | SOLE | 5,938,215 | 0 | 0 | ||
| Sutro BioPharma Inc | COM | 869367102 | 11,481 | 1,125,579 | SH | SOLE | 1,125,579 | 0 | 0 | ||
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 9,599 | 1,726,603 | SH | SOLE | 1,726,603 | 0 | 0 | ||
| Urovant Sciences Ltd | COM | G9381B108 | 1,452 | 157,480 | SH | SOLE | 157,480 | 0 | 0 | ||